Ticker Details
Carisma Therapeutics, Inc.
IPO Date:	February 3, 2014
Sector:	Healthcare
Industry:	Biotech
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 5.14%
Avg Daily Range (30 D):	$0.01 | 15.67%
Avg Daily Range (90 D):	$0.01 | 17.08%

Institutional Daily Volume
Avg Daily Volume:	1.62M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.17M

Trade Size
Avg Trade Size (Sh.):	423
Avg Trade Size (Sh.) (30 D):	2,028
Avg Trade Size (Sh.) (90 D):	2,555

Institutional Trades
Total Institutional Trades:	13
Avg Institutional Trade:	$3.26M
Avg Institutional Trade (30 D):	$.8M
Avg Institutional Trade (90 D):	$.8M
Avg Institutional Trade Volume:	.6M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.58M
Avg Closing Trade (30 D):	$3.25M
Avg Closing Trade (90 D):	$3.25M
Avg Closing Volume:	784.55K

News

Jul 26, 2025 @ 5:47 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 16, 2025 @ 3:32 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire

Jul 15, 2025 @ 12:31 AM $HAREHOLDER ALERT: The M&A Class Action Firm Launc... Source: Juan Monteverde

Jul 5, 2025 @ 1:48 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 1, 2025 @ 10:18 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$1.07	$-.23	$-.22
Diluted EPS	$1.07	$-.23	$-.22
Revenue	$45.3M	$M	$3.7M
Gross Profit
Net Income / Loss	$44.72M	$-9.77M	$-9.27M
Operating Income / Loss	$43.81M	$-5.78M	$-9.33M
Cost of Revenue
Net Cash Flow	$.78M	$-5.74M	$-10.17M
PE Ratio	0.03

Splits
Mar 08, 2023	2:1